Aptevo Therapeutics Inc.
APVO· Nasdaq
Aptevo Therapeutics Inc.
- Last sale
- Oct 6, 2026 · +0.83%
- Market cap
- $3.28M
- 1.8M shares
- Filings
- 732
Price
Oct 6, 2026 · IEX last sale
IEX last saleClose of record
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2022 | 2022-12-31 | $3,114,000 | reported | |
| FY 2021 | 2021-12-31 | $12,292,000 | reported | |
| FY 2020 | 2020-12-31 | $4,309,000 | reported | |
| FY 2019 | 2019-12-31 | $32,424,000 | reported | |
| FY 2018 | 2018-12-31 | $23,067,000 | reported | |
| FY 2017 | 2017-12-31 | $14,658,000 | reported | |
| FY 2016 | 2016-12-31 | $9,985,000 revised | reported | |
| FY 2015 | 2015-12-31 | $33,601,000 | reported |
Aptevo Therapeutics Inc. · CIK 1671584 · Engraved from SEC EDGAR
